Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM5 | P41594 | 1/20 | 0.35 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.32 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.32 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20813312 | 0.86 | GRM2 (0.32) | CYP11B1CYP11B2 | |
| SCHEMBL20813499 | 0.84 | CA12 (0.31) | GRM5 | |
| SCHEMBL20813702 | 0.83 | GRM5 (0.32) | GRM5 | |
| SCHEMBL20813529 | 0.82 | ACACB (0.37) | GRM5CYP11B1CYP11B2 | |
| SCHEMBL20813944 | 0.81 | — | — | |
| SCHEMBL20813942 | 0.81 | CYP11B1 (0.38) | CYP11B1CYP11B2 | |
| SCHEMBL20803269 | 0.80 | NPC1 (0.34) | — | |
| SCHEMBL20813521 | 0.79 | GRM5 (0.32) | GRM5 | |
| SCHEMBL20813752 | 0.78 | CYP11B1 (0.32) | CYP11B1CYP11B2 | |
| SCHEMBL20813900 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10676669-B2 | Compound having naphthalene ring, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2020-06-09 | — | — | US | disclosed |
| US-20190078019-A1 | COMPOUND HAVING NAPHTHALENE RING, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2019-03-14 | — | — | US | disclosed |
| EP-3453697-A1 | COMPOUND HAVING NAPHTHALENE RING, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT | JNC Corporation (JP) | 2019-03-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10676669-B2 | Compound having naphthalene ring, liquid crystal composition and liquid crystal display device | PYM1, CXCR1, CPNE4 | GRM5 3977/4885CYP11B1 1962/4885CYP11B2 1762/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.